These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23449600)

  • 21. Role of polymerase chain reaction in the diagnosis of Trichomonas vaginalis infection in human immunodeficiency virus-infected individuals from India (South).
    Paul H; Peter D; Pulimood SA; Abraham OC; Mathai E; Prasad JH; Kannangai R
    Indian J Dermatol Venereol Leprol; 2012; 78(3):323-7. PubMed ID: 22565432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Trichomonas vaginalis infection in women attending a major gynaecological hospital in Greece: a cross-sectional study.
    Piperaki ET; Theodora M; Mendris M; Barbitsa L; Pitiriga V; Antsaklis A; Tsakris A
    J Clin Pathol; 2010 Mar; 63(3):249-53. PubMed ID: 20203225
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women.
    Mavedzenge SN; Pol BV; Cheng H; Montgomery ET; Blanchard K; de Bruyn G; Ramjee G; Straten Av
    Sex Transm Dis; 2010 Jul; 37(7):460-6. PubMed ID: 20562586
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global epidemiology and control of Trichomonas vaginalis.
    Johnston VJ; Mabey DC
    Curr Opin Infect Dis; 2008 Feb; 21(1):56-64. PubMed ID: 18192787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trichomonas vaginalis infection: risk indicators among women attending for routine gynecologic examination.
    Verteramo R; Calzolari E; Degener AM; Masciangelo R; Patella A
    J Obstet Gynaecol Res; 2008 Apr; 34(2):233-7. PubMed ID: 18412787
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus.
    Moodley P; Wilkinson D; Connolly C; Moodley J; Sturm AW
    Clin Infect Dis; 2002 Feb; 34(4):519-22. PubMed ID: 11797180
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trichomonas vaginalis infection in southern Ghana: clinical signs associated with the infection.
    Squire DS; Lymbery AJ; Walters J; Ahmed H; Asmah RH; Thompson RCA
    Trans R Soc Trop Med Hyg; 2019 Jul; 113(7):359-369. PubMed ID: 30989196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trichomonas vaginalis in selected U.S. sexually transmitted disease clinics: testing, screening, and prevalence.
    Meites E; Llata E; Braxton J; Schwebke JR; Bernstein KT; Pathela P; Asbel LE; Kerani RP; Mettenbrink CJ; Weinstock HS
    Sex Transm Dis; 2013 Nov; 40(11):865-9. PubMed ID: 24113409
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for Trichomonas vaginalis in a Large High-Risk Population: Prevalence Among Men and Women Determined by Nucleic Acid Amplification Testing.
    Schwebke J; Merriweather A; Massingale S; Scisney M; Hill C; Getman D
    Sex Transm Dis; 2018 May; 45(5):e23-e24. PubMed ID: 29465684
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management.
    Schwebke JR; Hook EW
    J Infect Dis; 2003 Aug; 188(3):465-8. PubMed ID: 12870131
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk factors for prevalent and incident Trichomonas vaginalis among women attending three sexually transmitted disease clinics.
    Helms DJ; Mosure DJ; Metcalf CA; Douglas JM; Malotte CK; Paul SM; Peterman TA
    Sex Transm Dis; 2008 May; 35(5):484-8. PubMed ID: 18360314
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    Masha SC; Cools P; Sanders EJ; Vaneechoutte M; Crucitti T
    Sex Transm Infect; 2019 Feb; 95(1):36-42. PubMed ID: 30341233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trichomonas vaginalis among HIV-Infected women: are immune status or protease inhibitor use associated with subsequent T. vaginalis positivity?
    Magnus M; Clark R; Myers L; Farley T; Kissinger PJ
    Sex Transm Dis; 2003 Nov; 30(11):839-43. PubMed ID: 14603092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metronidazole resistance in Trichomonas vaginalis from highland women in Papua New Guinea.
    Upcroft JA; Dunn LA; Wal T; Tabrizi S; Delgadillo-Correa MG; Johnson PJ; Garland S; Siba P; Upcroft P
    Sex Health; 2009 Dec; 6(4):334-8. PubMed ID: 19917203
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multilocus sequence typing of Trichomonas vaginalis clinical samples from Amsterdam, the Netherlands.
    van der Veer C; Himschoot M; Bruisten SM
    BMJ Open; 2016 Oct; 6(10):e013997. PubMed ID: 27737887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trichomonas vaginalis and Mycoplasma genitalium: age-specific prevalence and disease burden in men attending a sexually transmitted infections clinic in Amsterdam, the Netherlands.
    van der Veer C; van Rooijen MS; Himschoot M; de Vries HJ; Bruisten SM
    Sex Transm Infect; 2016 Feb; 92(1):83-5. PubMed ID: 26283740
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prevalence of Gardnerella vaginalis, Trichomonas vaginalis and Candida albicans in the cytology clinic at Ibadan, Nigeria.
    Konje JC; Otolorin EO; Ogunniyi JO; Obisesan KA; Ladipo OA
    Afr J Med Med Sci; 1991 Mar; 20(1):29-34. PubMed ID: 1905467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Trichomonas vaginalis with sociodemographic factors and other STDs among female inmates in Lisbon.
    Garcia A; Exposto F; Prieto E; Lopes M; Duarte A; Correia da Silva R
    Int J STD AIDS; 2004 Sep; 15(9):615-8. PubMed ID: 15339370
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Community-based study of risk factors for Trichomonas vaginalis infection among women and their male partners in Moshi urban district, northern Tanzania.
    Klinger EV; Kapiga SH; Sam NE; Aboud S; Chen CY; Ballard RC; Larsen U
    Sex Transm Dis; 2006 Dec; 33(12):712-8. PubMed ID: 16755271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence and risk factors for
    Ijasan O; Okunade KS; Oluwole AA
    Niger Postgrad Med J; 2018; 25(1):21-26. PubMed ID: 29676341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.